Lantheus Holdings (LNTH) | Stock Overview & Key Data

Lantheus Holdings Inc. | Mid-cap | Healthcare

$81.86

0.45%

| Lantheus Holdings Stock Comparison:

Lantheus Holdings vs Zoetis Lantheus Holdings vs Haleon Plc - ADR Lantheus Holdings vs Regencell Bioscience Lantheus Holdings vs Elanco Animal Health Lantheus Holdings vs Alkermes plc Lantheus Holdings vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Lantheus Holdings Performance Comparison

Loading chart data...

Lantheus Holdings

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $80.35 High: $82.50

on June 30, 2025

52 Week Range

Low: $73.11 High: $126.89

on May 22, 2025

on July 16, 2024

All-Time High: $126.89 on July 15, 2024

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $5.6B

EPS i 3.51

P/E Ratio (TTM) i 23.07

Forward P/E i 11.68

P/B Ratio i 4.81

PEG Ratio i 11.68

Div. Yield i N/A

ROE i 24.11%

Beta i 0.105

Debt to Equity i 52.78

Financial Highlights

Profitability

Gross Margin i 63.77%

Operating Margin i 27.38%

Profit Margin i 16.55%

Returns and Earnings

Return on Assets (TTM) i 14.39%

Return on Equity (TTM) i 24.11%

EBITDA i $556.5M

Net Income (TTM) i $254.3M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Lantheus Holdings LNTH	5.60B Mid-cap	1.30%	8.34%	-16.13%	-8.16%	-7.82%	3.76%	20.76%	467.68%
Zoetis ZTS	70.27B Large-cap	-0.88%	-7.52%	-5.28%	-3.88%	-4.10%	-10.13%	-10.57%	13.17%
Haleon Plc - ADR HLN	47.20B Large-cap	-1.14%	-8.63%	0.78%	9.04%	9.85%	22.43%	39.95%	39.95%
Regencell Bioscience RGC	18.54B Large-cap	-28.10%	-98.06%	-46.55%	253.53%	253.53%	369.42%	-55.16%	62.29%
Elanco Animal Health ELAN	6.63B Mid-cap	6.97%	6.25%	36.00%	20.81%	18.51%	0.42%	-30.17%	-35.18%
Alkermes plc ALKS	4.83B Mid-cap	-2.22%	-6.53%	-13.36%	-0.59%	-0.49%	17.79%	-10.17%	45.30%

Ownership & Short Interest

Insider Ownership i 2.24%

Institutional Ownership i 116.07%

Shares Short i 8M

Short Ratio i 5.47

Short % of Shares Outstanding i 15.20%

Average 10-Day Volume i 936K

Average 90-Day Volume i 1M

Lantheus Holdings Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Lantheus Holdings would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is LNTH's 52-week high and low?

In the last 52 weeks, Lantheus Holdings reached a high of $126.89 (on July 16, 2024) and a low of $73.11 (on May 22, 2025).

What is the market cap and P/E ratio for LNTH?

Curious about Lantheus Holdings's size and valuation? Its market capitalization stands at 5.60B. When it comes to valuation, the P/E ratio (trailing twelve months) is 23.07, and the forward P/E (looking ahead) is 11.68.

Does LNTH pay dividends? If so, what's the yield?

As for dividends, Lantheus Holdings isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Lantheus Holdings's main competitors or similar companies to consider before investing?

When looking at Lantheus Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Zoetis ZTS	70.27B	Healthcare	Drug Manufacturers - Specialty & Generic	-10.13%	-10.57%
Haleon Plc - ADR HLN	47.20B	Healthcare	Drug Manufacturers - Specialty & Generic	22.43%	39.95%
Regencell Bioscience RGC	18.54B	Healthcare	Drug Manufacturers - Specialty & Generic	369.42%	-55.16%
Elanco Animal Health ELAN	6.63B	Healthcare	Drug Manufacturers - Specialty & Generic	0.42%	-30.17%
Alkermes plc ALKS	4.83B	Healthcare	Drug Manufacturers - Specialty & Generic	17.79%	-10.17%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Lantheus Holdings Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Lantheus Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 24.11%, the Debt to Equity ratio from the most recent quarter is 52.78, and its Gross Profit Margin stands at 63.77%.

What is the recent revenue and earnings growth for LNTH?

Looking at Lantheus Holdings's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 0.80%, and quarterly earnings saw a YoY growth of -44.30%.

How much of LNTH stock is held by insiders and institutions?

Wondering who owns Lantheus Holdings stock? Company insiders (like executives and directors) hold about 2.24% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 116.07%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.